Abstract

BackgroundOsteoporosis is a common comorbidity in non-cystic fibrosis (non-CF) bronchiectasis patients. We determined whether desaturation during 6-min walk test (6MWT) can be a predictor for osteoporosis risk.MethodsThis was a retrospective cross-sectional study. Sixty-six non-CF bronchiectasis patients were enrolled. Lung function, walking distance, the lowest oxygen saturation (SpO2), the fall in SpO2 (ΔSpO2), and the distance–saturation product (DSP) were determined during the 6MWT. Desaturators (n = 45) were defined as those with ΔSpO2 > 10% or the lowest SpO2 < 88%. Bone mineral density (BMD) was determined through dual-energy X-ray absorptiometry. The severity of non-CF bronchiectasis was evaluated using high-resolution computed tomography.ResultsOsteoporosis was evident in more desaturators (82%) than non-desaturators (43%, p < 0.01). BMD at the level of the femoral neck was significantly lower in desaturators than in non-desaturators (− 3.6 ± 1.1 vs. − 2.4 ± 0.9, p < 0.01). BMD was correlated positively with the lowest SpO2 and negatively with ΔSpO2 and severe exacerbations. In multivariate linear regression analysis, desaturation during 6MWT was the most significant predictive factor for osteoporosis (95% confidence interval − 1.60 to − 0.26, p = 0.01). Other risk factors included old age, low body mass index and severe exacerbation.ConclusionsExertional desaturation during the 6MWT was a significant predictive factor for osteoporosis in Asian non-CF bronchiectasis patients. The 6MWT may be useful in identifying the osteoporotic phenotype of non-CF bronchiectasis and increasing clinician awareness to promote early intervention.

Highlights

  • Osteoporosis is a common comorbidity in non-cystic fibrosis bronchiectasis patients

  • Statistical analysis We reported means, standard deviations (SD), and 95% confidence interval for the continuous variables and frequency or percentage for the categorical variables

  • The proportion of desaturators with osteoporosis (37/45, 82%) was higher than that of non-desaturators (9/21, 43%, p < 0.01)

Read more

Summary

Introduction

Osteoporosis is a common comorbidity in non-cystic fibrosis (non-CF) bronchiectasis patients. Non-cystic fibrosis (non-CF) bronchiectasis is a chronic lung disease characterized by irreversibly dilated and damaged bronchi and bronchioles [1]. It is associated with several important clinical traits, namely, poor mucus clearance, airflow obstruction, and chronic systemic inflammation. There is deterioration of pulmonary function, diminution of Osteoporosis is one of the most common comorbidities of non-CF bronchiectasis [3]. The prevalence of diminished bone density in patients with non-CF bronchiectasis is high with more than 25% of the patients having osteoporosis and approximately 40–80% having osteopenia [5]. In other chronic respiratory diseases such as cystic fibrosis, chronic obstructive pulmonary disease (COPD)

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call